Denis Hellebuyck

Mantis Photonics AB is a Swedish technology company that aims to prevent diseases by detecting pathologies earlier through a patented hyperspectral camera. The company is based in Lund, Sweden, and was founded in 2021. The camera takes hyperspectral images of the retina, providing functional details such as tissue physiology, morphology, and composition. The company's strategy is to use the retina, which is a unique spot in the body where you can observe three essential systems simultaneously\: blood, vision, and central nervous system, to screen for eye diseases, cardiovascular, and neurodegenerative diseases. The CEO is Denis Hellebuyck.

Mantis Photonics AB is a Swedish technology company that aims to prevent diseases by detecting pathologies earlier through a patented hyperspectral camera. The company is based in Lund, Sweden, and was founded in 2021. The camera takes hyperspectral images of the retina, providing functional details such as tissue physiology, morphology, and composition. The company's strategy is to use the retina, which is a unique spot in the body where you can observe three essential systems simultaneously\: blood, vision, and central nervous system, to screen for eye diseases, cardiovascular, and neurodegenerative diseases. The CEO is Denis Hellebuyck.

Mantis Photonics AB is a Swedish technology company that aims to prevent diseases by detecting pathologies earlier through a patented hyperspectral camera. The company is based in Lund, Sweden, and was founded in 2021. The camera takes hyperspectral images of the retina, providing functional details such as tissue physiology, morphology, and composition. The company's strategy is to use the retina, which is a unique spot in the body where you can observe three essential systems simultaneously\: blood, vision, and central nervous system, to screen for eye diseases, cardiovascular, and neurodegenerative diseases. The CEO is Denis Hellebuyck.

Mantis Photonics AB is a Swedish technology company that aims to prevent diseases by detecting pathologies earlier through a patented hyperspectral camera. The company is based in Lund, Sweden, and was founded in 2021. The camera takes hyperspectral images of the retina, providing functional details such as tissue physiology, morphology, and composition. The company's strategy is to use the retina, which is a unique spot in the body where you can observe three essential systems simultaneously\: blood, vision, and central nervous system, to screen for eye diseases, cardiovascular, and neurodegenerative diseases. The CEO is Denis Hellebuyck.